Legal & General Group’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.3K Sell
3,969
-15,276
-79% -$47.5K ﹤0.01% 3208
2025
Q1
$65K Hold
19,245
﹤0.01% 2702
2024
Q4
$109K Buy
19,245
+7,597
+65% +$43.1K ﹤0.01% 2717
2024
Q3
$68.1K Buy
11,648
+1,797
+18% +$10.5K ﹤0.01% 2761
2024
Q2
$77.9K Buy
9,851
+4,941
+101% +$39.1K ﹤0.01% 2752
2024
Q1
$45.7K Buy
4,910
+602
+14% +$5.61K ﹤0.01% 2787
2023
Q4
$36.4K Hold
4,308
﹤0.01% 2855
2023
Q3
$33.4K Sell
4,308
-410
-9% -$3.18K ﹤0.01% 2911
2023
Q2
$54K Buy
+4,718
New +$54K ﹤0.01% 2867
2021
Q2
Sell
-4,627
Closed -$22K 3656
2021
Q1
$22K Buy
4,627
+784
+20% +$3.73K ﹤0.01% 3105
2020
Q4
$27K Hold
3,843
﹤0.01% 2983
2020
Q3
$41K Sell
3,843
-1,010
-21% -$10.8K ﹤0.01% 2760
2020
Q2
$61K Buy
4,853
+39
+0.8% +$490 ﹤0.01% 2675
2020
Q1
$44K Sell
4,814
-848
-15% -$7.75K ﹤0.01% 2637
2019
Q4
$79K Buy
5,662
+915
+19% +$12.8K ﹤0.01% 2669
2019
Q3
$81K Hold
4,747
﹤0.01% 2592
2019
Q2
$130K Buy
4,747
+1,091
+30% +$29.9K ﹤0.01% 2457
2019
Q1
$70K Buy
3,656
+457
+14% +$8.75K ﹤0.01% 2608
2018
Q4
$30K Hold
3,199
﹤0.01% 2909
2018
Q3
$61K Hold
3,199
﹤0.01% 2683
2018
Q2
$63K Buy
3,199
+264
+9% +$5.2K ﹤0.01% 2653
2018
Q1
$55K Sell
2,935
-1,425
-33% -$26.7K ﹤0.01% 2713
2017
Q4
$72K Sell
4,360
-141
-3% -$2.33K ﹤0.01% 2735
2017
Q3
$92K Buy
4,501
+987
+28% +$20.2K ﹤0.01% 2693
2017
Q2
$32K Hold
3,514
﹤0.01% 3023
2017
Q1
$46K Sell
3,514
-538
-13% -$7.04K ﹤0.01% 2887
2016
Q4
$52K Buy
4,052
+1,911
+89% +$24.5K ﹤0.01% 2882
2016
Q3
$26K Hold
2,141
﹤0.01% 2774
2016
Q2
$23K Buy
+2,141
New +$23K ﹤0.01% 2816